Gotlib, J., Mascarenhas, J., Rampal, R., Yacoub, A., Li, H., Santamaria, J., Halloran, M., Pemmaraju, N. (2025). A multicenter, open-label phase 1 study of INCB160058, a first-in-class JAK2V617F mutant–selective inhibitor, in patients with myelofibrosis, polycythemia vera, or essential thrombocythemia. Blood. https://doi.org/10.1182/blood-2025-2051